Webinars

If you are embarking on your clinical development plan, consider a non-invasive in vivo evaluation of drug delivery systems. Scintigraphy gives you the power to study drugs in gastrointestinal organs, providing you with valuable data earlier on in the drug development process. In this webinar, our featured speakers cover:

Achieving Orphan Drug Designation is a significant step enabling your product to be licensed faster, in a cost-efficient manner, and achieve market exclusivity for 10 years. Watch this 1-hour on-demand webinar where you will gain a practical overview of the steps to achieve orphan status including: For more information on rare diseases, take a look at our rare […]

Early-phase oncology trials are the first stage in testing new cancer treatments. This usually encompasses phase I and phase II of the three main phases of clinical trials, where patients are amongst the first to test a new treatment. Early-phase oncology trials generally test gradually increased dosage levels of an experimental drug. The toxicity and […]

Discussion topics include: Despite the benefits of orphan drug development, cash burn minimization is one of the major challenges faced by developers. While guidelines exist for efficient orphan drug development, they should be adapted to challenges presented by each of the more than 7,000 recognized rare diseases. The clinical development of orphan drugs represents a […]